<\/p>\n\n\n\n
Treister N, Schubert MS, Fall-Dickson JM. Oral chronic graft vs host disease. In: Vogelsang GB, Pavletic SZ, eds. Chronic Graft-Versus-Host Disease: Interdisciplinary Management. New York: Cambridge University; 2009:182\u2013198.<\/p>\n\n\n\n
Mays JW, Fassil H, Edwards DA, Pavletic SZ, Bassim CW. Oral chronic graftversus-host disease: current pathogenesis, therapy, and research. Oral Dis. 2013;19(4):327\u2013346.<\/p>\n\n\n\n
Jagasia M, Arora M, Flowers ME, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012;119(1):296\u2013307.<\/p>\n\n\n\n
Atkinson K, Horowitz MM, Gale RP, et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990;75(12):2459\u201364.<\/p>\n\n\n\n
Kuten-Shorrer M, Woo SB, Treister NS. Oral graft-versus-host disease. Dent Clin North Am. 2014;58(2):351-68.<\/p>\n\n\n\n
Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012;12(6):443\u201358.<\/p>\n\n\n\n
Weiden PL, Sullivan KM, Flournoy N, et al. Antileukemic effect of chronic graftversus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981;304(25):1529\u201333.<\/p>\n\n\n\n
Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin North Am 2008;52(1):79\u2013109 viii-ix.<\/p>\n\n\n\n
Treister NS, Cook EF Jr, Antin J, et al. Clinical evaluation of oral chronic graftversus-host disease. Biol Blood Marrow Transplant 2008;14(1):110\u20135.<\/p>\n\n\n\n
Treister N, Duncan C, Cutler C, et al. How we treat oral chronic graft-versus-host disease. Blood 2012;120(17):3407\u201318.<\/p>\n\n\n\n
Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2015;21(3):389\u2013401.e1.<\/p>\n\n\n\n
Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graftversus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005;11(12):945\u201356.<\/p>\n\n\n\n
Mielcarek M, Martin PJ, Leisenring W, et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003;102(2):756\u201362.<\/p>\n\n\n\n
Elad S, Aljitawi O, Zadik Y. Oral graft-versus-host disease: a pictorial review and a guide for dental practitioners. Int Dent J. 2020 Jun 28. doi: 10.1111\/idj.12584.<\/p>\n\n\n\n
Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15(6):825\u20138.<\/p>\n\n\n\n
Dignan FL, Clark A, Amrolia P, et al. Diagnosis and management of acute graftversus-host disease. Br J Haematol 2012;158(1):30\u201345.<\/p>\n\n\n\n
Shulman HM, Sale GE, Lerner KG, et al. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978;91(3):545\u201370.<\/p>\n\n\n\n
Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003;9(4):215\u201333.<\/p>\n\n\n\n
Imanguli MM, Alevizos I, Brown R, et al. Oral graft-versus-host disease. Oral Dis 2008;14(5):396\u2013412.<\/p>\n\n\n\n
Meier JK, Wolff D, Pavletic S, et al. Oral chronic graft-versus-host disease: report from the International Consensus Conference on Clinical Practice in cGVHD. Clin Oral Investig 2011;15(2):127\u201339.<\/p>\n\n\n\n
Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow. Transplantation 2006;12(3):252\u201366.<\/p>\n\n\n\n
Lee SJ, Wolff D, Kitko C, et al. Measuring therapeutic response in chronic graft-versus-host disease. national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group Report. Biol Blood Marrow Transpl 2015;21(6):984\u201399.<\/p>\n\n\n\n
Margaix-Mu\u00f1oz M, Bag\u00e1n JV, Jim\u00e9nez Y, Sarri\u00f3n MG, Poveda-Roda R. Graft-versus-host disease affecting oral cavity. A review. J Clin Exp Dent. 2015;7(1):e138-45.<\/p>\n\n\n\n
Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology working group report. Biol Blood Marrow Transplant 2006;12(1):31\u201347.<\/p>\n\n\n\n
Fall-Dickson JM, Cordes S, Berger AM. Oral complications. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia: Wolters Kluwer; 2019:2094\u20132108.<\/p>\n\n\n\n
Jaglowski SM, Blazar BR. How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD. Blood Adv. 2018;2(15):2012\u20132019.<\/p>\n\n\n\n
Fall-Dickson JM, Pavletic SZ, Mays JW, Schubert MM. Oral Complications of Chronic Graft-Versus-Host Disease. J Natl Cancer Inst Monogr. 2019;2019(53): lgz007.<\/p>\n\n\n\n
Treister N, Li S, Lerman MA, et al. Narrow-band UVB phototherapy for management of oral chronic graft-versus-host disease. Photodermatol Photoimmunol Photomed 2015;31(2):75\u201382.<\/p>\n\n\n\n
Elad S, Jensen SB, Raber-Durlacher JE, et al. Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers. Support Care Cancer 2015;23(6):1615\u201322.<\/p>\n\n\n\n
Carpenter PA, Kitko CL, Elad S, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transpl 2015;21(7):1167\u201387.<\/p>\n\n\n\n
Elad S, Zadik Y, Zeevi I, et al. Oral cancer in patients after hematopoietic stem-cell transplantation: long-term follow-up suggests an increased risk for recurrence. Transplantation 2010;90(11):1243\u20134.<\/p>\n\n\n
<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"
Oral graft-versus-host disease The aim of this e-learning tool is to present readers with information on the epidemiology, clinical characteristics, diagnosis and management of oral graft-versus-host disease. Graft-versus-host disease (GVHD) is an immunologic condition which develops following allogeneic hematopoietic stem cell transplantation (HSCT). It is a major cause of non-relapse morbidity and mortality in this […]<\/p>\n","protected":false},"author":1,"featured_media":446,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"jetpack_featured_media_url":"https:\/\/opmdcare.com\/wp-content\/uploads\/oral-gvhd.jpeg","_links":{"self":[{"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/posts\/407"}],"collection":[{"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/comments?post=407"}],"version-history":[{"count":2,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/posts\/407\/revisions"}],"predecessor-version":[{"id":1075,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/posts\/407\/revisions\/1075"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/media\/446"}],"wp:attachment":[{"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/media?parent=407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/categories?post=407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/opmdcare.com\/wp-json\/wp\/v2\/tags?post=407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}